Literature DB >> 19665610

Cloning and characterization of Rhipicephalus appendiculatus voraxinalpha and its effect as anti-tick vaccine.

Shinji Yamada1, Satoru Konnai, Saiki Imamura, Takuya Ito, Misao Onuma, Kazuhiko Ohashi.   

Abstract

Male tick-derived voraxinalpha and voraxinbeta, a pair of testicular proteins, are transferred to female via copulation to stimulate female blood feeding in the tick Amblyomma hebraeum (A. hebraeum). Immunized animals with recombinant (r-)voraxinalpha and voraxinbeta have been shown as highly resistant to the tick infestation. In this study, we describe the cloning and characterization of voraxinalpha homologue from the tick Rhipicephalus appendiculatus (R. appendiculatus), the major vector for East Coast fever in Eastern Africa. The sequence analysis of the R. appendiculatus voraxinalpha indicated that the deduced amino acid sequence had high similarity with voraxinalpha of the tick A. hebraeum and Dermacentor variabilis, suggesting that voraxinalpha is conserved in different tick genera. Quantitative RT-PCR and Western blotting analysis showed that male voraxinalpha was predominantly expressed in testis and its expression was induced by blood feeding. R. appendiculatus voraxinalpha was not secreted into the host during tick feeding and was detected in mated female hemolymph as measured by Western blotting. Preliminary vaccination of rabbits with r-voraxinalpha elicited the humoral immunity and conferred protective immunity against female ticks, resulting in the reduced fed weight. These results suggest that r-voraxinalpha could be a good candidate as anti-tick vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665610     DOI: 10.1016/j.vaccine.2009.07.072

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Cloning and molecular analysis of voraxin-α gene of Rhipicephalus (Boophilus) microplus.

Authors:  Binod Kumar; Srikanta Ghosh
Journal:  J Parasit Dis       Date:  2014-05-25

2.  Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.

Authors:  Yusuke Murase; Kenji Hosoya; Takachika Sato; Sangho Kim; Masahiro Okumura
Journal:  Oncol Rep       Date:  2022-01-28       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.